BVXV Developing anti-IL-17 NanoAb

BVXVDelisted Stock  USD 1.35  0.03  2.17%   
Slightly above 61% of BiondVax Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in BiondVax Pharmaceuticals suggests that many traders are alarmed regarding BiondVax Pharmaceuticals' prospects. BiondVax Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, BiondVax Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
  
By David Bautz, PhD NASDAQBVXV READ THE FULL BVXV RESEARCH REPORT Business Update Developing Anti-IL-17 NanoAb BiondVax Pharmaceuticals Ltd. is a biopharmaceutical company that is focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. In March 2022, the company signed a

Read at finance.yahoo.com
Yahoo News
  

BiondVax Pharmaceuticals Fundamental Analysis

We analyze BiondVax Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BiondVax Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BiondVax Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Insiders

Shares Owned By Insiders Comparative Analysis

BiondVax Pharmaceuticals is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

BiondVax Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BiondVax Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of BiondVax Pharmaceuticals could also be used in its relative valuation, which is a method of valuing BiondVax Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

BiondVax Pharmaceuticals Related Equities

ADTXAditxt   5.56   
0%
66.0%
GOVXGeoVax Labs   4.68   
0%
55.0%
ARMPArmata Pharmaceuticals   4.46   
0%
53.0%
ANTXAN2 Therapeutics   4.35   
0%
51.0%
ATXIAvenue Therapeutics   4.30   
0%
51.0%
CANFCan Fite   3.95   
0%
46.0%
SABSSAB Biotherapeutics   1.95   
0%
23.0%
SLRXSalarius Pharmaceuticals   0.60   
0%
7.0%
ORMPOramed Pharmaceuticals   0.42   
0%
4.0%
MOLNMolecular Partners   0.19   
2.0%
0%
PHVSPharvaris   0.36   
4.0%
0%
MLYSMineralys Therapeutics,   0.39   
4.0%
0%
MDWDMediwound   0.73   
8.0%
0%
VCNXVaccinex   0.91   
10.0%
0%
KTTAPasithea Therapeutics   2.15   
25.0%
0%
ADILAdial Pharmaceuticals   2.86   
34.0%
0%
RVPHReviva Pharmaceuticals   3.23   
38.0%
0%
BLRXBioLineRx   4.35   
51.0%
0%
RNAZTranscode Therapeutics   5.66   
67.0%
0%
SRZNSurrozen   5.95   
70.0%
0%
PEPGPepGen   8.41   
100.0%
0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Consideration for investing in BiondVax Stock

If you are still planning to invest in BiondVax Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BiondVax Pharmaceuticals' history and understand the potential risks before investing.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance